Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.
about
Consequences of hyperoxia and the toxicity of oxygen in the lungRelationship between CRP and hypofibrinolysis: Is this a possible mechanism to explain the association between CRP and outcome in critically ill patients?Nebulized heparin for patients under mechanical ventilation: an individual patient data meta-analysisChronic Rhinosinusitis and the Coagulation SystemEnhanced fibrinolysis protects against lung ischemia-reperfusion injuryTargeted delivery of therapeutics to endothelium.Amelioration of Duchenne muscular dystrophy in mdx mice by elimination of matrix-associated fibrin-driven inflammation coupled to the αMβ2 leukocyte integrin receptorTissue factor signals airway epithelial basal cell survival via coagulation and protease-activated receptor isoforms 1 and 2Effect of stretch on structural integrity and micromechanics of human alveolar epithelial cell monolayers exposed to thrombin.Plasmin cleaves the juxtamembrane domain and releases truncated species of the urokinase receptor (CD87) from human bronchial epithelial cells.Inflammatory Responses Regulating Alveolar Ion Transport during Pulmonary Infections.Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) prevents lipopolysaccharide (LPS)-induced, sepsis-related severe acute lung injury in mice.Role of the lysophospholipid mediators lysophosphatidic acid and sphingosine 1-phosphate in lung fibrosis.Placenta growth factor (PlGF), a novel inducer of plasminogen activator inhibitor-1 (PAI-1) in sickle cell disease (SCD).Plasminogen activator inhibitor type 1 gene polymorphism and sepsis.A phase I study evaluating the pharmacokinetics, safety and tolerability of an antibody-based tissue factor antagonist in subjects with acute lung injury or acute respiratory distress syndrome.Smad6s regulates plasminogen activator inhibitor-1 through a protein kinase C-beta-dependent up-regulation of transforming growth factor-beta.The SERPINE2 gene is associated with chronic obstructive pulmonary disease.Acute traumatic coagulopathy among major trauma patients in an urban tertiary hospital in sub Saharan Africa.Regulation of endothelial cell inflammation and lung polymorphonuclear lymphocyte infiltration by transglutaminase 2.Human models of acute lung injury.Environmental risk factors for acute respiratory distress syndromePlasminogen activator inhibitor-1 inhibits factor VIIa bound to tissue factor.Critical role of non-muscle myosin light chain kinase in thrombin-induced endothelial cell inflammation and lung PMN infiltrationAirway tissue plasminogen activator prevents acute mortality due to lethal sulfur mustard inhalationTargeting antioxidant and antithrombotic biotherapeutics to endothelium.Urokinase-type plasminogen activator (uPA) induces pulmonary microvascular endothelial permeability through low density lipoprotein receptor-related protein (LRP)-dependent activation of endothelial nitric-oxide synthase.Thrombin promotes proliferation of human lung fibroblasts via protease activated receptor-1-dependent and NF-κB-independent pathways.Wood bark smoke induces lung and pleural plasminogen activator inhibitor 1 and stabilizes its mRNA in porcine lung cellsPreconditioning with endoplasmic reticulum stress ameliorates endothelial cell inflammation.Microhemorrhage is an early event in the pulmonary fibrotic disease of PECAM-1 deficient FVB/n mice.Nebulized heparin is associated with fewer days of mechanical ventilation in critically ill patients: a randomized controlled trialPlasminogen activator inhibitor-1 in cigarette smoke exposure and influenza A virus infection-induced lung injury.Disorders of lung matrix remodeling.Coagulation, inflammation, and the risk of neonatal white matter damage.An acidic microenvironment sets the humoral pattern recognition molecule PTX3 in a tissue repair modeUrokinase plasminogen activator regulates pulmonary arterial contractility and vascular permeability in miceKinetics of lung tissue factor expression and procoagulant activity in bleomycin induced acute lung injury.Association of protein C and type 1 plasminogen activator inhibitor with primary graft dysfunction.Airway tissue factor-dependent coagulation activity in response to sulfur mustard analog 2-chloroethyl ethyl sulfide
P2860
Q21296803-D29E422D-EA6A-4D25-B531-41DD2F961B27Q24804596-347D35F1-7FDE-47A6-B1B6-8C2B7016E302Q26753103-6A41756E-8984-408B-9E4F-3A39EA7595B9Q26851357-C6DF80E3-ABD7-4EB5-9477-C7E9FF717AF6Q30436290-9A127294-5886-4EC3-B51E-71D02CAB8476Q30475849-A59F51CE-8834-4920-8CB5-BC82E47609C2Q30512264-45E48AC3-D1FF-493C-805B-240D26F49948Q30532482-8654CE8E-8929-4B66-8663-0A12216D3E3AQ30806126-E7E694B1-0708-4003-90CC-0CEB3C2C05FBQ31110978-A4839CCC-9D46-44BD-84FF-EE14E433B0B3Q33572332-FDF27232-6F48-4431-B287-77AABD0532D6Q33718932-8235C6EA-2DE9-49CF-90E8-04AEA5D1E687Q33756825-9A6B095C-F0D9-4854-9F33-88740EB372D3Q33883207-275CC9A3-0051-4AD6-93A5-35491EAE04CFQ33990846-2E17E680-0487-4DDD-AEC9-1349152B86A1Q34160584-5B8B49E3-236A-4367-81E2-4C5F295628AFQ34395261-480920DB-DA21-48FE-8D85-1CE53F57C67BQ34398902-EC8F60C4-B6D1-4A53-B7D5-767DFC287E86Q34476444-9DD18E55-6AC3-46CF-A207-95EE09DD055BQ34536570-20225546-ED00-4663-A4E9-A4D780D60993Q34611737-02C51704-92F0-4E24-8E6E-80C6FAAE1C31Q34629386-C795A2E1-FBEF-4E4B-A275-3A89D7F004BCQ34630452-537069CE-B127-4267-BAA1-07E07D20E7E5Q34652770-E2CA4E36-F7CB-4406-8DBF-65CC0DF6AD8AQ34760271-49461ABD-9B85-4861-8633-60560A671EA8Q34935960-0DE8E78E-1989-4417-A32D-0BEBED499213Q35067747-5716B673-476F-4755-882C-D22931C89F7FQ35093428-F79A983F-52E0-4869-8CE3-83165BF8F78AQ35115926-7F2F3422-E564-4879-BFFE-F119F9BB295DQ35377412-E156E9DB-6981-4033-B621-A81B2400D054Q35552757-3E272B3C-F361-4328-BB09-0B993AAEFEFFQ35559236-BC4E6DBE-7FA7-47ED-8BBE-4495AC500358Q35620083-BC9704FB-68A5-44EA-BF2B-6D5BFC22443AQ35628568-FD8A9AB5-C417-4DFA-8E6D-59B2F2E023F8Q35671058-F5637F0B-08DD-4C46-8BAD-0CB623D84F5AQ35671242-F398BB48-4439-48E1-922E-3E24F93640FDQ35684859-5F157352-E2CA-4227-B915-15E17F831B2EQ35829051-C9301CD1-F522-4492-B9C0-5210B750D944Q35855114-0EDC4C88-1973-4DD7-9971-05194568DAA9Q35950219-BA1511E5-D061-44AB-BCD7-ADD63C910E3D
P2860
Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.
@ast
Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.
@en
type
label
Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.
@ast
Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.
@en
prefLabel
Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.
@ast
Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.
@en
P1476
Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.
@en
P2093
Steven Idell
P304
P356
10.1097/01.CCM.0000057846.21303.AB
P407
P433
P577
2003-04-01T00:00:00Z